Students, residents, and fellows are invited to submit a poster for the 2019 NAPCRG Annual Meeting to be held November 16-20 in Toronto, Ontario. Proposals on any topic relating to primary care research are welcome from researchers throughout North America and the world.
GENERAL RULES FOR ALL SUBMISSIONS:
- Submissions must be submitted online through the NAPCRG website (www.napcrg.org) no later than July 31, 2019.
- Submission must involve research that is in progress on July 31, 2019.
- A non-refundable $20 US is required for each submission.
- All presenters must register for the conference and pay the appropriate registration fees.
Letters of acceptance will be emailed by late September.
Note: Once you complete payment for your submission you will have the opportunity to add additional presenters to the submission.
The NAPCRG submission system considers co-authors and co-presenters one and the same. Anyone that wishes to be listed on the abstract will need to create a profile, including co-authors and co-presenters.
The lead presenter is the individual that will be listed in the program book as the main contact for the presentation. All other names will appear in the mobile app and on the abstract.
Have questions about your submission? Check out our FAQ's for submitting your presentation.
Additional Questions? Contact Jill Haught via email at email@example.com or via phone at 757-581-7459.
Please note: The general call for papers closed April 16, 2019.
SUBMISSION FORMAT INSTRUCTIONS:
IMPORTANT: Our CME requires each submission to include at least 2 learning objectives. Please follow these instructions!
- List at least 2 learning objectives using these guidelines: Clearly describe what you want learners to take away and implement after the session in active, measurable terms (e.g. - define, interpret, explain, apply).
- Each objective must be specific, concise, and limited to one sentence.
- Example - "On completion of this session, participants should be able to identify and describe the three primary tenets of the Patient Self-Efficacy Model”.
- Limit abstract to 2,500 characters. This does not include the title or authors.
- Abstracts must be in English.
- Type the body of the abstract as one paragraph. The abstract must be written in the third person.
- The abstract should contain the appropriate subheadings described below.
- The abstract should not contain charts, graphics, references, or acknowledgments.
- Abstracts will be distributed as submitted. Before submitting your abstract, check carefully to make sure it contains no spelling or typographical errors.
Title: Type title in bold at the top of the abstract.
Author(s): List author(s) with presenter listed first separated by semicolons.
Context: The abstract should begin with a sentence or two summarizing the rationale for the study, providing the clinical (or other) reason for the study question. In addition, the author should give a sentence or two about the importance of this work to family medicine/primary care.
Objective: State the objective or study question addressed (eg, to determine whether…). If more than one objective is addressed, the main objective should be indicated and only key secondary objectives stated.
Human Subjects Review: Describe the level of Institutional Review Board approval that the study received.
Design: Describe the basic design of the study. Use descriptors such as double blind, placebo controlled RCT, cohort, case control survey, case series, cost-effectiveness analysis, or qualitative study. For new analyses of existing data sets (secondary data analysis), the data set should be named and the basic study design disclosed.
Setting: Describe the study setting(s) such as general community, a primary care or referral center, private or institutional practice, or ambulatory or hospitalized care. Patients or Other Participants: State the important eligibility (inclusion and exclusion) criteria and key sociodemographic features of participants. Provide numbers of participants and how they were selected.
Intervention/Instrument (as pertinent): Describe the essential features of any interventions. The intervention should be named by its common clinical name (eg, the nonproprietary drug name propranolol).
Main and Secondary Outcome Measures (if any): Give the primary study outcome measurements. Measurements that require explanation for a general medical readership should be defined.
Anticipated Results: Give the main anticipated results of the study.
Conclusions: State methodological or conceptual problem that is being posed.
Note: For brevity, parts of the abstract should be written in phrases rather than complete sentences (eg, “Design: Double-blind randomized trial”